Cargando…

Value of T1 mapping on gadoxetic acid-enhanced MRI for microvascular invasion of hepatocellular carcinoma: a retrospective study

BACKGROUND: To evaluate the utility of non-invasive parameters derived from T1 mapping and diffusion-weighted imaging (DWI) on gadoxetic acid-enhanced MRI for predicting microvascular invasion (MVI) of hepatocellular carcinoma (HCC). METHODS: A total of 94 patients with single HCC undergoing partial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rao, Chenyi, Wang, Xinquan, Li, Minda, Zhou, Guofeng, Gu, Hongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189724/ https://www.ncbi.nlm.nih.gov/pubmed/32345247 http://dx.doi.org/10.1186/s12880-020-00433-y

Ejemplares similares

Value of gadoxetic acid-enhanced MRI for microvascular invasion of small hepatocellular carcinoma: a retrospective study
por: Zhou, Meng, et al.
Publicado: (2021)

Predicting microvascular invasion in hepatocellular carcinoma: A dual‐institution study on gadoxetate disodium‐enhanced MRI
por: Jiang, Hanyu, et al.
Publicado: (2022)

Analysis of the Performance of Gadoxetic Acid Disodium MRI in Predicting Microvascular Invasion of Hepatocellular Carcinoma
por: Chen, Jiao, et al.
Publicado: (2022)

Multi-scale and multi-parametric radiomics of gadoxetate disodium–enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm
por: Chong, Huan-Huan, et al.
Publicado: (2021)

Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI
por: Palm, Viktoria, et al.
Publicado: (2018)

Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma
por: Ricke, Jens, et al.
Publicado: (2020)

Benign nodules mimicking hepatocellular carcinoma on gadoxetic acid-enhanced liver MRI
por: Song, Kyoung Doo, et al.
Publicado: (2015)

Gadoxetic acid-enhanced MRI combined with T1 mapping and clinical factors to predict Ki-67 expression of hepatocellular carcinoma
por: Qiu, Ganbin, et al.
Publicado: (2023)

Predictive value of gadoxetic acid–enhanced MRI for posthepatectomy liver failure: a systematic review
por: Wang, Qiang, et al.
Publicado: (2021)

The Value of TTPVI in Prediction of Microvascular Invasion in Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2020)

Quantification of liver function using gadoxetic acid-enhanced MRI
por: Poetter-Lang, Sarah, et al.
Publicado: (2020)

The imaging findings of Peliosis hepatis on gadoxetic acid enhanced MRI
por: Yoshida, Morikatsu, et al.
Publicado: (2020)

Predicting histologic differentiation of solitary hepatocellular carcinoma up to 5 cm on gadoxetate disodium-enhanced MRI
por: Yang, Ting, et al.
Publicado: (2023)

A rare case of MRI of myxoid hepatocellular adenoma with gadoxetic acid uptake
por: Yang, Tze Wei Wilson, et al.
Publicado: (2023)

Peritumoral Dilation Radiomics of Gadoxetate Disodium-Enhanced MRI Excellently Predicts Early Recurrence of Hepatocellular Carcinoma without Macrovascular Invasion After Hepatectomy
por: Chong, Huanhuan, et al.
Publicado: (2021)

Hepatocellular carcinoma composed of two different histologic types: imaging features on gadoxetic acid-enhanced liver MRI
por: Kim, Seung Hyun, et al.
Publicado: (2013)

Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology
Publicado: (2017)

Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers
por: Kim, Yeun-Yoon, et al.
Publicado: (2019)

Detection of hepatocellular carcinoma in a population at risk: iodine-enhanced multidetector CT and/or gadoxetic acid-enhanced 3.0 T MRI
por: Qiong, Lan, et al.
Publicado: (2022)

Value of MR histogram analyses for prediction of microvascular invasion of hepatocellular carcinoma
por: Huang, Ya-Qin, et al.
Publicado: (2016)

Preoperative prediction of cytokeratin-19 expression for hepatocellular carcinoma using T1 mapping on gadoxetic acid-enhanced MRI combined with diffusion-weighted imaging and clinical indicators
por: Zhao, Yue, et al.
Publicado: (2023)

Gadoxetic acid-enhanced MRI of hepatocellular carcinoma: Diagnostic performance of category-adjusted LR-5 using modified criteria
por: Park, Jae Hyon, et al.
Publicado: (2020)

Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study
por: Ye, Zheng, et al.
Publicado: (2019)

Focal nodular hyperplasia: hepatobiliary enhancement patterns on gadoxetic-acid contrast-enhanced MRI
por: van Kessel, C. S., et al.
Publicado: (2012)

Histogram Analysis of Gadoxetic Acid-Enhanced MRI for Quantitative Hepatic Fibrosis Measurement
por: Kim, Honsoul, et al.
Publicado: (2014)

Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers
por: Lochrin, Sarah E., et al.
Publicado: (2021)

Gadoxetic Acid (Gd-EOB-DTPA)-Enhanced MRI versus Gadobenate Dimeglumine (Gd-BOPTA)-Enhanced MRI for Preoperatively Detecting Hepatocellular Carcinoma: an Initial Experience
por: Park, Yulri, et al.
Publicado: (2010)

Gadoxetic acid-enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression
por: Elkilany, Aboelyazid, et al.
Publicado: (2020)

Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure
por: Zhu, Wang-Shu, et al.
Publicado: (2020)

Correction to: Gadoxetic acid‑enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression
por: Elkilany, Aboelyazid, et al.
Publicado: (2021)

Association between relative liver enhancement on gadoxetic acid enhanced magnetic resonance images and histologic grade of hepatocellular carcinoma
por: Jin, Young-Joo, et al.
Publicado: (2017)

Gadoxetic Acid-Enhanced MRI and Sonoelastography: Non-Invasive Assessments of Chemoprevention of Liver Fibrosis in Thioacetamide-Induced Rats with Sho-Saiko-To
por: Chen, Ya-Wen, et al.
Publicado: (2014)

The value of the signal intensity of peritumoral tissue on Gd-EOB-DTPA dynamic enhanced MRI in assessment of microvascular invasion and pathological grade of hepatocellular carcinoma
por: Wang, Li-Li, et al.
Publicado: (2021)

Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
por: Kurucay, Mustafa, et al.
Publicado: (2017)

Gadoxetic Acid-Enhanced MRI-Based Radiomics Signature: A Potential Imaging Biomarker for Identifying Cytokeratin 19-Positive Hepatocellular Carcinoma
por: Hu, Xiaojun, et al.
Publicado: (2023)

Delayed tumour enhancement on gadoxetate-enhanced MRI is associated with overall survival in patients with colorectal liver metastases
por: Cheung, Helen M. C., et al.
Publicado: (2018)

Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials
por: Huh, Jimi, et al.
Publicado: (2019)

Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial
por: Öcal, Osman, et al.
Publicado: (2021)

MRI characterization of focal liver lesions in non-cirrhotic patients: assessment of added value of gadoxetic acid-enhanced hepatobiliary phase imaging
por: Moosavi, Bardia, et al.
Publicado: (2020)

Radiomics Analysis on Gadoxetate Disodium-Enhanced MRI Predicts Response to Transarterial Embolization in Patients with HCC
por: Cannella, Roberto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7ibtvain4oed7hm7o5g7iamu55